Diagnosis of pulmonary arterial hypertension preceding the confirmation of systemic sclerosis in a patient with Raynaud's phenomenon

Microvasc Res. 2022 Jan:139:104267. doi: 10.1016/j.mvr.2021.104267. Epub 2021 Oct 16.

Authors

Shahna Tariq¹, Jan Willem Cohen Tervaert¹, Mohammed Osman²

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of Alberta, 8-130 Clinical Sciences Building, Edmonton, Alberta T6G 2B7, Canada.
² Division of Rheumatology, Department of Medicine, University of Alberta, 8-130 Clinical Sciences Building, Edmonton, Alberta T6G 2B7, Canada. Electronic address: mosman@ualberta.ca.

PMID: 34666100
DOI: 10.1016/j.mvr.2021.104267

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anticoagulants / therapeutic use
Antihypertensive Agents / therapeutic use
Capillaries / diagnostic imaging*
Cardiac Catheterization*
Female
Fingers / blood supply*
Humans
Microscopic Angioscopy*
Middle Aged
Predictive Value of Tests
Pulmonary Arterial Hypertension / diagnosis*
Pulmonary Arterial Hypertension / drug therapy
Pulmonary Arterial Hypertension / etiology
Raynaud Disease / diagnostic imaging*
Raynaud Disease / drug therapy
Raynaud Disease / etiology
Scleroderma, Systemic / complications
Scleroderma, Systemic / diagnostic imaging*
Scleroderma, Systemic / drug therapy
Treatment Outcome

Substances

Anticoagulants
Antihypertensive Agents